A B S T R A C T Wiskott-Aldrich syndrome is characterized by numerous humoral and cellular immune abnormalities including anergy, defective antibody production, and increased immunoglobulin synthesis. To define better the mechanisms of defective cellular immunity in this disorder, lymphoproliferative responses, lymphokine production, and the chemotactic responsiveness of mononuclear leukocytes (MNL) from patients with Wiskott-Aldrich syndrome were quantitated. Peripheral blood lymphocytes from these patients produced normal amounts of a lymphocyte-derived chemotactic factor (LDCF); however, their lymphoproliferative responses were frequently depressed, particularly to antigenic stimuli. In the absence of exogenous antigens or mitogens, lymphocytes from patients with Wiskott-Aldrich syndrome produced significantly more LDCF than unstimulated normal lymphocytes. In 
INTRODUCTION
Wiskott-Aldrich syndrome (WAS) 1 is a sex-linked recessive disorder which is characterized by severe thrombocytopenia, eczema, and recurrent infections (1) (2) (3) . This disease generally culminates in death during infancy or early childhood (4). Patients with this syndrome also manifest a perplexing spectrum of humoral and cellular immune abnormalities (5) . Natural antibodies are absent or low in titer, and antibody production after specific immunization, particularly with polysaccharide antigens, is strikingly defective in this disease (6) . Patients with WAS, however, have normal numbers of circulating bone marrow-derived (B) lymphocytes (7), elevated serum levels of IgA, IgD, and IgE, and markedly accelerated synthesis and catabolism of immunoglobulins G and A (8) .
Evaluation of cellular immune function in WAS has revealed additional abnormalities. Clinically, children with this syndrome are anergic to common microbial antigens, fail to manifest contact sensitivity to dinitrochlorobenzene, and show markedly delayed skin allograft rejection (6) . In contrast, lymphocyte-proliferative responses to optimal concentrations of nonspecific mitogens are usually normal (6) ; lymphocyte-mediated cytotoxicity responses are intact (9, 10); and these patients have a normal proportion of thymus-derived (T) lymphocytes in their circulation (11). However, the proliferative response of WAS lymphocytes to specific lAbbreviations used in this paper: B cells, bone marrow- antigens and allogeneic cells is profoundly impaired (12) .
In the present study we investigated the production by WAS lymphocytes of a lymphokine that is chemotactic for mononuclear leukocytes (MNL) and the response of MNL from these patients to standard chemotactic stimuli. These studies were designed to investigate further the basic immunologic defect(s) and possible mechanism(s) of anergy in this disease. Our findings suggest that abnormal regulation and control of lymphocyte-derived chemotactic factor (LDCF) synthesis exists in WAS and that this abnormality may contribute to the impaired delayed hypersensitivity characteristic of this disease.
METHODS
Patients. Seven boys with well-documented WAS were studied at the Clinical Center, National Institutes of Health. Whenever possible, the patients were studied as outpatients during periods of relative well-being. The patients ranged in age from 13 mo to 10 yr. 32 healthy individuals of varying ages served as controls.
Chemotactic factors. Human C5a, the biologically active cleavage product of the fifth component of human complement, was isolated from normal human serum after endotoxin activation (13).
Human LDCF was prepared as previously described (14). Briefly, blood from patients and normal donors was drawn into heparinized (20-30 U/ml) syringes. The cells were sedimented by gravity or with dextran, triply washed, and the lymphocyte-rich cell population was cultured in RPMI 1640 (Grand Island Biological Co., Grand Island, N. Y.) at either 3 X 106 cells/ml in 1-ml volumes in 1-dram flat-bottomed glass vials, or 2 X 106 cells/ml in 2-ml volumes in 13 X 125 mm plastic tubes (Falcon Plastics, Oxnard, Calif.). Media were supplemented with 0.5% vol/vol heated (56°C for 30 min) homologous Ab Rh+ plasma, 50 U penicillin, 50 gg streptomycin, and 2 mM glutamine/ ml. Leukocytes were incubated for 24 h at 37°C in a humidified atmosphere of 95% and 5% C02. After incubation, supernates were cleared of cells by centrifugation (1,500 g for 15 min) and tested for chemotactic activity. Supernates from cultures stimulated with a mitogen or antigen at the beginning of an experiment are referred to as "stimulated", while supernates from cultures reconstituted with the appropriate stimulant after incubation are referred to as "unstimulated".
Chemotactic assay and expression of results. A modification (14) of Boyden's original technique (15), using 5 jum Nuclepore (Wallabs, Inc., San Rafael, Calif.) membranes, was employed. MNL from patients and normal subjects, for use in the chemotactic assay, were obtained from peripheral blood by Ficoll-Hypaque equilibrium centrifugation as previously described (16) . All experiments were standardized so that each Boyden chamber contained 4 X 106 Ficoll-Hypaque-purified MNL. Chemotactic determinations were routinely performed in triplicate and 20 oil immersion fields quantitated per replicate.
The production of LDCF by stimulated WAS or normal lymphocytes is expressed as a function of the number of normal MNL (mean-one SE) which migrated in response to 0.5 ml of WAS or normal culture supernate, respectively. In preliminary studies, volumes less than 0.5 ml were tested, confirming that at this volume saturation of the assay was not obscuring differences Lymphocyte transformation. Lymphocyte transformation was performed as previously described (20) , with several modifications. Leukocyte-rich plasma was obtained from heparinized peripheral blood by gravity sedimentation. Duplicate 1-ml cultures containing 5 X 105 leukocytes were established in medium RPMI 1640 supplemented with 2 mM glutamine, 100 U penicillin, 100 gg streptomycin/ml, and 10% autologous or homologous plasma. Cultures were incubated at 37°C in loosely capped flat-bottomed glass vials in a humidified atmosphere of 95% air and 5% C02 for 5 days. Cell suspensions were pulse-labeled with tritiated thymidine ([8H] TdR) for the final 4i h of the culture period and the acid-precipitable radioactivity was determined. Leukocytes from patients and normal volunteers were always cultured simultaneously.
Lymphocyte stimulants. The following stimulants were used in a total of 1 ml of culture medium Normal MNL were incubated with LDCF or media alone and washed, and the chemotactic response of these cells to LDCF was tested (Table V) . It can be seen that the cells incubated with LDCF migrated substantially less than the cells incubated with media alone. In a series of subsequent experiments, MNL from normal donors were incubated either in WAS or in homologous normal plasma and washed, and the chemotactic responsiveness of these cells to both C5a and LDCF was tested (Table VI) . It is evident that MNL incubated in WAS plasma failed to respond as well as cells incubated in normal plasma. Specifically, the chemotactic response to C5a of MNL incubated in normal plasma was 93.0±12.3, compared with 57.8+7.7 (P < 0.025) for MNL incubated in WAS plasma. Similarly, the response to LDCF was 106.4±13.8 for cells incubated in normal plasma, versus 67.8+11.1 for cells incubated in WAS plasma (P < 0.050). These data suggest that prior exposure of MNL to a chemotactic agent can induce a state of refractoriness (desensitization) to a subsequent chemotactic stimulus, and that the plasma of WAS patients also inhibits the chemotaxis of MNL.
Characterization of the inhibitory factor on these WAS plasma samples showed it to be: (a) nondialyz- variety of abnormalities of both cellular and humoral immunity have been identified. In the present study, we have examined lymphocyte-proliferative responses, LDCF production, and MNL chemotactic responsiveness in WAS patients. One of the most striking findings of the study was the demonstration that lymphocytes from WAS patients, when cultured in the absence of exogenous stimuli, produced significantly more LDCF than unstimulated normal lymphocytes. In fact, the amount of unstimulated LDCF produced by WAS cells frequently equaled that produced by normal lymphocytes only after antigen or mitogen stimulation.
The cause for this spontaneously elevated rate of LDCF synthesis by WAS lymphocytes is unclear. The possibility that it simply reflects a response to infection appears unlikely. Firstly, these patients were specifically studied during periods when they were not obviously infected. Secondly, we have studied numerous patients with a variety of diseases, including other primary and secondary immunodeficiency disorders, without observing other than sporadic instances of increased spontaneous LDCF production. Included in these other groups were patients with congenital and acquired hypogammaglobulinemia, ataxia telangiectasia, isolated IgA deficiency with chronic sinopulmonary infection, Hodgkin's and non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Sezary's syndrome, and chronic mucocutaneous candidiasis. In fact, many of the patients in these groups were experiencing acute or chronic infections, such as bronchiectasis, acute and chronic moniliasis, and acute herpes labialis.
Elevated LDCF production by unstimulated WAS lymphocytes may, in fact, reflect a more basic defect in this disease. We have previously shown that WAS patients are synthesizing immunoglobulins G and A at up to 10 times the normal rate, in spite of defective specific antibody synthesis (8) . In addition, we have identified IgG monoclonal paraproteins in the sera of a significant proportion of patients with this syndrome (21) . Thus, this disease is clearly associated with hyperactivity of the B lymphoid cell system. It has generally been assumed that lymphokines such as macrophage inhibitory factor (MIF) and LDCF are products of activated T lymphocytes, and in fact we have previously demonstrated that spleen cells from agammaglobulinemic chickens totally devoid of B cells (22) and lymphocytes from agammaglobulinemic humans 2 produce LDCF. However, Yoshida, Sonozaki, and Cohen (23) (25) and in some patients with malignant diseases 3 (26) . The defective MNL chemotaxis in WAS patients observed in this study was associated with a humoral factor capable of decreasing the chemotactic response of normal MNL. Van Epps and Williams (27) have recently presented evidence of an immunoglobulin that inhibits chemotaxis in anergic patients with a variety of conditions. However, characterization of the inhibitor found in WAS plasma indicates that it is heat-stable, nondialyzable, and not immunoglobulin in nature. The possibility that this humoral factor develops as a consequence of the repeated infections experienced by WAS patients is unlikely, since we have been unable to identify any inhibitory activity in the plasmas of patients with chronic infections associated with either cystic fibrosis or chronic granulomatous disease.' Despite the fact that WAS plasma is inhibitory to MINL chemotaxis, partial characterization showed that the inhibitory factor in these plasma samples shared many properties with LDCF. In this regard, it was found that normal MNL were deactivated by incubation in LDCF, thus becoming less responsive to subsequent chemotactic stimuli. In view of this ability of LDCF to chemotactically deactivate MNL, it is extremely interesting that those WAS patients whose unstimulated lymphocytes produced the highest levels of LDCF also had the most pronounced defect in MNL chemotactic responsiveness. Thus, the two defects described in this report, elevated unstimulated LDCF synthesis and defective MNL chemotactic responsiveness, may be interrelated and may contribute to anergy in WAS by the mechanism of chemotactic deactivation. The increased production of LDCF by unstimulated WAS lymphocytes might also contribute to the anergy characteristic of this disease by a different mechanism. MNL are the predominant cells found in delayed hypersensitivity reactions and are thought to accumulate at these sites in response to chemotactic factors elaborated by specifically stimulated lymphocytes. If LDCF production by unstimulated lymphocytes is increased, then any potential chemotactic gradient produced as a result of a specific lymphocyte response would be diminished. This Fig. 1 ) had mildly reduced respon or exceeded the normal mean). How ous observations, in this study lym patients showed a markedly defect sponse to specific antigens, in thi candida. In yet another dissociation ished proliferative responses, WA duced as much LDCF as did norm stimulated with either specific anti mitogens. Undoubtedly, some of 1 be explained on the grounds that l size LDCF are distinct from those has been previously shown for pr production (28) . These multiple e tion of the immune response provii for the concept that one of the ma lies in the initiation and control of ness (6, 29) .
